ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Transitionbio
The role involves applying molecular biology, protein biochemistry, and biophysical techniques to support drug discovery projects, including construct design, protein expression, purification, and assay development, while collaborating with multidisciplinary teams.
Transition Bio is a biotech company pioneering condensate-targeted drug discovery, focused on therapeutics that modulate biomolecular condensates to address previously intractable biology. By combining the technology and data engines of Harvard’s Weitz Lab and the University of Cambridge’s Knowles Lab, they have built an end-to-end condensate drug discovery platform grounded in molecular-level insights. Transition Bio uses this platform to accelerate target identification, screening, and lead optimization for novel medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Transitionbio.
Transitionbio didn’t post a salary, so this is our estimate from similar listings.